Europe's alcohol-related harm persists due to underutilized, inconsistently applied evidence-based policies

Europe bears the highest burden of alcohol-related harm, encompassing major health, social, and economic consequences like crimes, road traffic injuries, and lost productivity. This region leads the World Health Organization (WHO) in alcohol consumption, related harms, and deaths. Excessive alcohol intake contributes to liver disease, including Alcoholic Liver Disease (ALD) and Metabolic dysfunction-associated Alcoholic Liver Disease (MetALD), and is responsible for a substantial number of premature deaths. Addressing this pervasive public health crisis requires effective, evidence-based interventions, yet their consistent application remains a significant challenge across the continent.

This policy paper synthesized existing evidence on alcohol policies and identified critical implementation gaps across Europe. The authors reviewed the current landscape of alcohol consumption and its associated harms, drawing on data from the WHO and other sources to highlight the scale of the problem. They specifically examined the effectiveness of various interventions, such as taxation, minimum unit pricing, and marketing restrictions, by assessing their current utilization and consistency of application. The analysis also considered the preparedness of healthcare systems and the impact of social factors like stigma and health literacy on the detection and treatment of alcohol use disorder (AUD) and ALD/MetALD.

Europe exhibits the highest levels of alcohol consumption and related harms globally, with males consuming 21.0 L and females 7.3 L of pure alcohol per capita yearly, equivalent to 45.5 g and 15.7 g daily, respectively. This consumption pattern contributes to over four years of life lost for men who use alcohol in the EU, and alcohol is responsible for approximately one out of every eleven deaths across Europe. The primary obstacle to reducing this burden is identified as implementation gaps, despite strong evidence for effective interventions. Specifically, policies like taxation, minimum unit pricing, and marketing restrictions are found to be underutilized or inconsistently applied across European nations. Healthcare systems demonstrate limited preparedness, with poor integration leading to missed opportunities for timely detection, intervention, and treatment of AUD, ALD, and MetALD. Furthermore, stigma, social inequities, and low health literacy significantly hinder help-seeking behaviors and delay diagnosis.

Implementation gaps are the primary obstacle to reducing alcohol-related harm, with strong evidence showing that taxation, minimum unit pricing, and marketing restrictions remain underutilised or inconsistently applied across Europe.